Arrested plasmodium liver stages as experimental anti-malaria vaccines

Human Vaccines

Volumn 7, Issue SUPPL., 2011, Pages 16-21

  Matuschewski, Kai ^a   Hafalla, Julius Clemence ^b   Borrmann, Steffen ^c,d   Friesen, Johannes ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

Malaria; Plasmodium; Sporozoite; Whole organism vaccine

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; DRUG CARRIER; GENETICALLY ARRESTED PARASITE VACCINE; LIVE VACCINE; MALARIA VACCINE; PRIMAQUINE; RADIATION ATTENUATED SPOROZOITE VACCINE; SPOROZOITE VACCINE; UNCLASSIFIED DRUG;

CELL CYCLE ARREST; CELLULAR IMMUNITY; DRUG COATING; DRUG COST; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; GENETIC IMMUNIZATION; HUMAN; IMMUNE RESPONSE; MALARIA; NONHUMAN; PLASMODIUM (LIFE CYCLE STAGE); REVIEW; SPOROZOITE; VACCINATION;

ANTIMALARIALS; HUMANS; LIVER; MALARIA VACCINES; PLASMODIUM; VACCINATION; VACCINES, ATTENUATED;

EID: 79956336419     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.0.14557     Document Type: Review

References (74)

1. Guinovart MM, Navia M, Tanner M, Alonso PL. Malaria: burden of disease. Curr Mol Med 2006; 6:137-40; PMID: 16515506.
2. Haldar K, Murphy SC, Milner D Jr, Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol Mech Dis 2007; 2:217-49; PMID: 18039099; DOI: 10.1146/annurev.pathol.2. 010506.091913.
3. Glynn JR, Bradley DJ. Inoculum size, incubation period and severity of malaria. Analysis of data from malaria therapy records. Parasitology 1995; 110:7-19; PMID: 7845714.
4. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002; 415:673-9; PMID: 11832955; DOI:10.1038/415673a.
5. Hartgers FC, Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol 2006; 2:497-506; PMID: 16965285; DOI: 10.1111/j.1365-3024.2006.00901.x.
6. Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, Bwanaisa L, et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection and outcome. J Infect Dis 2007; 19:895-904; PMID: 17299721.
7. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600; PMID: 1865923; DOI:10.1038/352595a0.
8. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006; 28:51-60; PMID: 16438676; DOI: 10.1111/j.1365-3024.2006.00808.x.
9. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9:725-32; PMID: 18563083; DOI:10.1038/ni.f.205.
10. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, Weiss GE, et al. A prospective analysis of the Ab responses to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci USA 2010; 107:6958-63; PMID: 20351286; DOI: 10.1073/pnas.1001323107.
11. Weiss GE, Traore B, Kayentao K, Ongoiba A, Doumbo S, Kone Y, et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog 2010; 6:1000912; PMID: 20502681; DOI:10.1371/journal.ppat.1000912.
12. Silvie O, Matuschewski K, Mota MM, Prudencio M. Interactions of the malaria parasite and its mammalian host. Curr Opin Microbiol 2008; 11:352-9; PMID: 18644249; DOI:10.1016/j.mib.2008.06.005.
13. Hafalla JC, Silvie O, Matuschewski K. Cell biology and immunology of malaria. Immun Rev 2011; In press.
14. Matuschewski K. Hitting malaria before it hurts: attenuated Plasmodium liver stages. Cell Mol Life Sci 2007; 64:3007-11; PMID: 17876525; DOI: 10.1007/s00018-007-7263-z.
15. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature 2002; 415:694-701; PMID: 11832958; DOI:10.1038/415694a.
16. Malkin E, Dubovsky F, Moree M. Progress towards the development of malaria vaccines. Trends Parasitol 2006; 22:292-5; PMID: 16707275; DOI:10.1016/j.pt.2006.05.002.
17. Matuschewski K. Vaccine development against malaria. Curr Opin Immunol 2006; 18:449-57; PMID: 16765576; DOI:10.1016/j.coi.2006.05.004.
18. Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 2004; 71:239-47; PMID: 15331843.
19. Freund J, Sommer HE, Walter AW. Immunization against malaria: vaccination of ducks with killed parasites incorporated with adjuvants. Science 1945; 102:200-2; PMID: 17787139; DOI: 10.1126/science.102.2643.200.
20. Freund J, Thomson KJ, Sommer HE, Walter AW, Schenkein EL. Immunization of Rhesus monkeys against malarial infection (P. knowlesi). Science 1945; 102:202-4; PMID: 17787140; DOI: 10.1126/science.102.2643.202.
21. Mulligan HW, Russell PF, Mohan BN. Active immunization of fowls against Plasmodium gallinaceum by injections of killed homologous sporozoites. J Mal Inst India 1941; 4:25-34.
22. Russell PF, Mulligan HW, Mohan BN. Active immunization of fowls against sporozoites but not trophozoites of Plasmodium gallinaceum by injections of homologous sporozoites. J Mal Inst Ind 1942; 4:311-9.
23. Richards WHG. Active immunization of chicks against Plasmodium gallinaceum by inactivated homologous sporozoites and erythrocytic parasites. Nature 1966; 212:1492-4; DOI:10.1038/2121492a0.
24. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 1967; 216:160-2; PMID: 6057225; DOI:10.1038/216160a0.
25. Vanderberg JP, Nussenzweig RS, Most H, Orton C. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. J Parasitol 1968; 54:1175-80; PMID: 5757691.
26. Nussenzweig RS, Vanderberg JP, Most H, Orton C. Specificity of protective immunity produced by X-irradiated Plasmodium berghei sporozoites. Nature 1969; 222:488-9; PMID: 5768632; DOI:10.1038/216160a0.
27. Nussenzweig R, Vanderberg J, Most H. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity. Mil Med 1968; 134:1176-82; PMID: 4987036.
28. Vanderberg J, Nussenzweig R, Most H. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. Mil Med 1968; 134:1183-90; PMID: 4987037.
29. Vanderberg JP. Reflections on early malaria vaccine studies, the first successful human malaria vaccination and beyond. Vaccine 2009; 27:2-9; PMID: 18973784; DOI: 10.1016/j.vaccine.2008.10.028.
30. Nardin E, Nussenzweig RS. T cell responses to preerythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Ann Rev Immunol 1993; 11:687-727; PMID: 8476576; DOI: 10.1146/annurev.iy.11.040193.003351.
31. + T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol 2006; 36:1179-86; PubMed PMID: 16598821; DOI: 10.1002/eji.200535712.
32. Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000; 165:1453-62; PMID: 10903750.
33. Hafalla JC, Cockburn IA, Zavala F. Protective and pathogenic roles of CD8+ T cells during malaria infection. Parasite Immunol 2006; 28:15-24; PMID: 16438672; DOI: 10.1111/j.1365-3024.2006.00777.x.
34. Overstreet MG, Cockburn IA, Chen YC, Zavala F. Protective CD8 T cells against Plasmodium liver stages: immunbiology of an 'unnatural' immune response. Immunol Rev 225:272-83; PMID: 18837788; DOI: 10.1111/j.1600-065X.2008.00671.x.
35. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ 1979; 57:165-73; PMID: 120766.
36. Clyde DF, Most H, McCarthy VC, Vanderberg JP. Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973; 266:169-77; PMID: 4583408.
37. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185:1155-64; PMID: 11930326; DOI: 10.1086/339409.
38. Epstein JE, Rao S, Williams F, Freilich D, Luke T, Sedegah M, et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis 2007; 196:145-54; PMID: 17538895; DOI: 10.1086/518510.
39. Ballou R. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine. Microbes Infect 2007; 9:761-6; PMID: 17412630; DOI:10.1016/j.micinf.2007.02.006.
40. Luke TC, Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 2003; 206:3803-8; PMID: 14506215; DOI: 10.1242/jeb.00644.
41. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccines 2010; 6:97-106; PMID: 19946222; DOI: 10.4161/hv.6.1.10396.
42. Enea V, Ellis J, Zavala F, Arnot DE, Asavanich A, Masuda A, et al. DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science 1984; 225:628-30; PMID: 6204384.
43. Ballou WR. The development of the RTS, S malaria vaccine candidate: challenges and lessons. Parasite Immunol 2009; 31:492-500; PMID: 19691554; DOI: 10.1111/j.1365-3024.2009.01143.x.
44. Cohen J, Nussenzweig V, Vekemans J, Leach A. From the circumsporozoite protein to the RTS, S candidate vaccine. Hum Vaccines 2010; 6:90-6; PMID: 19806009; DOI: 10.4161/hv.6.1.9677.
45. Berry AE, Gardner MJ, Caspers GJ, Roos DS, Berriman M. Curation of the Plasmodium falciparum genome. Trends Parasitol 2004; 20:548-52; PMID: 15522662; DOI:10.1016/j.pt.2004.09.003.
46. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 2008; 105:305-10; PMID: 18172196; DOI: 10.1073/pnas.0710780104.
47. Balu B, Adams JH. Advancements in transfection technologies for Plasmodium. Int J Parasitol 2007; 37:1-10; PMID: 17113093; DOI:10.1016/j.ijpara. 2006.10.001.
48. Vaughan A, Wang R, Kappe SHI. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Human Vaccines 2010; 6:107-13; PMID: 19838068; DOI: 10.4161/hv.6.1.9654.
49. Mueller AK, Labaied M, Kappe SHI, Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005; 433:164-7; PMID: 15580261; DOI:10.1038/nature03188.
50. Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 2005; 102:3022-7; PMID: 15699336; 10.1073/pnas.0408442102.
51. Van Dijk MR, Douradinha B, Franke-Fayard B, Heussler V, van Dooren MW, van Schaijk B, et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci USA 2005; 102:12194-9; PMID: 16103357.
52. Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 2007; 75:3758-68; PMID: 17517871.
53. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, et al. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 2007; 196:608-16; PMID: 1762484.
54. Falae A, Combe A, Amaladoss A, Carvalho T, Menard R, Bhanot P. Role of Plasmodium berghei cGMP-dependent protein kinase in late liver stage development. J Biol Chem 2010; 285:3282-8; PMID: 19940133.
55. Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, Schlüter D. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J. Pathol 2007; 171:107-15; PMID: 17591958.
56. + T cells. J Infect Dis 2007; 196:599-607; PMID: 17624847.
57. Van Schaijk BC, Janse CJ, van Gemert GJ, van Dijk MR, Gego A, Franetich JF, et al. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary hepatocytes. PLoS One 2008; 3:3549; PMID: 18958160.
58. Van Buskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, et al. Preeryhrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci USA 2009; 106:13004-9; PMID: 19625622.
59. Silvie O, Goetz K, Matuschewski K. A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development. PLoS Pathog 2008; 4:1000086; PMID: 18551171.
60. Aly AS, Mikolajczak SA, Rivera HS, Camargo N, Jacobs-Lorena V, Labaied M, et al. Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Mol Microbiol 2008; 69:152-63; PMID: 18466298.
61. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006; 444:937-40; PMID: 17151604.
62. Beaudoin RL, Strome CPA, Mitchell F, Tubergen TA. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp Parasitol 1977; 42:1-5; PMID: 324783.
63. Belnoue E, Costa FTM, Frankenberg T, Vigario AM, Voza T, Leroy N, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004; 172:2487-95; PMID: 15470029.
64. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, et al. Protection against malaria challenge by sporozoite inoculation. N Engl J Med 2009; 361:468-77; PMID: 19641203.
65. Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 1987; 329:164-7; PMID: 3306406.
66. John CC, Tande AJ, Moormann AM, Sumba PO, Lanar DE, Min XM, et al. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis 2008; 197:519-26; PMID: 18275273.
67. World Health Organization. Guidelines for the Treatment of Malaria. World Health Organization, Geneva 2006.
68. Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009; 199:899-903; PMID: 19434915.
69. Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, et al. Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 2000; 355:2041-5; PMID: 10885356.
70. Friesen J, Silvie O, Putrianti ED, Hafalla JCR, Matuschewski K, Borrmann S. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2010; 2:49; PMID: 2063085.
71. Fichera ME, Roos DS. A plastid organelle as a drug target in apicomplexan parasites. Nature 1997; 390:407-9; PMID: 9389481.
72. Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA. In vitro efficacy, resistance selection and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J Biol Chem 2007; 282:2494-504; PMID: 17110371.
73. Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: A randomized trial. JAMA 2009; 302:962-8; PMID: 19724043.
74. Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, et al. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis 2005; 191:1582-8; PMID: 15838784.